- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04374890
Evaluation of a New Supporting Ostomy Product
May 1, 2020 updated by: Coloplast A/S
The aim of the study is to evaluate if the new supporting product influences wear time.
It is the expectation that median wear time is slightly reduced in the period when subjects are using the supporting product with their ostomy appliance.
Long-term benefits of the test product may be less skin redness, less worry of leakage and/or improvement in quality of life and social activities.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Humlebæk, Denmark, 3050
- Recruiting
- Coloplast A/S
-
Contact:
- Thomas Krarup Simonsen
- Phone Number: +45 49111111
- Email: clinical-studies@coloplast.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Have given written informed consent
- Be at least 18 years of age and have full legal capacity
- Have had a stoma for more than three months
- Have intact skin on the area used in the evaluation meaning no broken skin and only minor discoloration of the skin (assessed by investigator)
- Be able to use one of the three test products (i.e. Ø50, Ø60 and Ø70 mm)
- Have an ileostomy- or colostomy with liq-uid output (Bristol scale type 6-7)
- Currently using a SenSura Mio product (1pc/2pc Flat/Convex/Concave)
- Be willing and suitable (determined by the study nurse) to use the test product with-out using a paste/mouldable ring during the test periods
- Have self-reported problems with leakage* (three times within 14 days) *Leakage: Leakage is defined as output from the stoma on the backside of the baseplate (underneath the baseplate)
Exclusion Criteria:
- Currently receiving or have within the past 2 month received radio- and/or chemotherapy
- Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment
- Are pregnant or breastfeeding
- Participating in other interventional clinical investigations or have previously participat-ed in this investigation. Exception: Participation in other Coloplast sponsored clinical investigations is accepted under the circumstances that the subject has paused the activities in the investigation and are otherwise complying with the inclusion and exclusion criteria of this (CP308) protocol
- Known sensitivity towards test product
- Known sensitivity towards acrylate
- Users with a pacemaker
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental
|
3 weeks of baseline followed by 2x3 weeks use of the test device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wear time
Time Frame: 9 weeks
|
To evaluate the subject change pattern (wear time) when using the supporting product in 'real-life' situations'
|
9 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
May 1, 2020
Primary Completion (Anticipated)
December 1, 2020
Study Completion (Anticipated)
December 1, 2020
Study Registration Dates
First Submitted
April 29, 2020
First Submitted That Met QC Criteria
May 1, 2020
First Posted (Actual)
May 5, 2020
Study Record Updates
Last Update Posted (Actual)
May 5, 2020
Last Update Submitted That Met QC Criteria
May 1, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- CP308
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stoma Ileostomy
-
University of California, San DiegoNot yet recruitingIleostomy; Complications | Stoma IleostomyUnited States
-
11 Heath and Technologies LimitedThe Cleveland ClinicUnknownIleostomy; Complications | Ileostomy - StomaUnited States
-
Chang Gung Memorial HospitalConvaTect, TaiwanUnknownStoma Ileostomy | Stoma ColostomyTaiwan
-
Coloplast A/SCompleted
-
Massachusetts General HospitalRecruitingSurgery | Ileostomy - Stoma | Colostomy StomaUnited States
-
BBraun Medical SASRecruitingEnterostomy | Stoma Ileostomy | Stoma ColostomySpain
-
Hospital de BasurtoAlberto Loizate Totoricaguena; Pedro García AlonsoUnknownIleostomy; Complications | Ileostomy - Stoma | Stoma Ileostomy | Ileus ParalyticSpain
-
Coloplast A/SCompletedIleostomy - Stoma | Colostomy StomaDenmark, Sweden
-
University of Southern CaliforniaUnknownIleostomy - Stoma | Colostomy StomaUnited States
-
Coloplast A/SCompletedIleostomy - Stoma | Colostomy - StomaDenmark